Esslingen, Baden-Württemberg, Germany Funds with similar focus
| Fund Name | Location |
| C&B Capital | Atlanta, Georgia, United States |
| Converge Ventures | Hilliard, Ohio, United States |
| Executive Channel International | Australia, New South Wales, Pyrmont |
| GDA Group | - |
| Goldin Ventures | Macungie, Pennsylvania, United States |
| Hong Kong Qibao International Group | China, Hong Kong, Hong Kong Island |
| John Templeton Foundation | Conshohocken, Pennsylvania, United States |
| Monarq Incubator | New York, New York, United States |
| Natixis Private Equity | France, Ile-de-France, Paris |
| NH Foods | Japan, Osaka, Osaka Prefecture |
| Orca Bay Partners | Seattle, United States, Washington |
| Prasetia Dwidharma | Indonesia, Jakarta Pusat, Jakarta Raya |
| SDVentures | New York, New York, United States |
| Spansion | California, Sunnyvale, United States |
| SpringCapital Investment | Australia, New South Wales, Sydney |
| Strategic Global Investments | California, Carlsbad, United States |
| Strathclyde University Incubator | Glasgow, Glasgow City, United Kingdom |
| Telemedia | Bellefonte, Pennsylvania, United States |
| Telindus | Camberley, Surrey, United Kingdom |
| Western Union | Colorado, Englewood, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BioTeSys | $608K | 10 May 2007 | Germany, Bavaria, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BioTeSys | $608K | 10 May 2007 | Germany, Bavaria, Germany |
